
TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings
TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于参与设立私募股权投资基金的公告 | 2024-01-02 | Chinese | |
| 关于2022年股票期权激励计划2023年第四季度自主行权结果暨股份变动的公告 | 2024-01-02 | Chinese | |
| 关于收到《民事判决书》暨诉讼进展公告 | 2023-12-25 | Chinese | |
| 关于控股股东所持公司部分股份质押及解除质押的公告 | 2023-12-22 | Chinese | |
| 关于公司2023年度对外担保预计的进展公告 | 2023-12-12 | Chinese | |
| 德恒上海律师事务所关于天域生态环境股份有限公司2023年第五次临时股东大会的法律意见书 | 2023-12-08 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
2 filings
| |||||
| 38190935 | 关于参与设立私募股权投资基金的公告 | 2024-01-02 | Chinese | ||
| 38190922 | 关于2022年股票期权激励计划2023年第四季度自主行权结果暨股份变动的公告 | 2024-01-02 | Chinese | ||
|
2023
13 filings
| |||||
| 38190904 | 关于收到《民事判决书》暨诉讼进展公告 | 2023-12-25 | Chinese | ||
| 38190881 | 关于控股股东所持公司部分股份质押及解除质押的公告 | 2023-12-22 | Chinese | ||
| 38190868 | 关于公司2023年度对外担保预计的进展公告 | 2023-12-12 | Chinese | ||
| 38190852 | 德恒上海律师事务所关于天域生态环境股份有限公司2023年第五次临时股东大会的法律意见书 | 2023-12-08 | Chinese | ||
| 38190807 | 2023年第五次临时股东大会决议公告 | 2023-12-08 | Chinese | ||
| 38190793 | 公司章程(2023年11月修订) | 2023-11-22 | Chinese | ||
| 38190778 | 董事会提名委员会工作细则(2023年11月修订) | 2023-11-22 | Chinese | ||
| 38190761 | 独立董事工作制度(2023年11月修订) | 2023-11-22 | Chinese | ||
| 38190748 | 关于调整第四届董事会审计委员会委员的公告 | 2023-11-22 | Chinese | ||
| 38190732 | 关于继续开展商品期货套期保值业务的公告 | 2023-11-22 | Chinese | ||
| 38190717 | 关于召开2023年第五次临时股东大会的通知 | 2023-11-22 | Chinese | ||
| 38190706 | 董事会薪酬与考核委员会工作细则(2023年11月修订) | 2023-11-22 | Chinese | ||
| 38190692 | 关于修订《公司章程》及部分制度的公告 | 2023-11-22 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TIANYU BIO-TECHNOLOGY CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57798/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57798 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57798 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57798 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57798}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TIANYU BIO-TECHNOLOGY CO.,LTD. (id: 57798)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.